risperidone has been researched along with Hemophilia A in 2 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
Hemophilia A: The classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Starr, JM | 2 |
2 other studies available for risperidone and Hemophilia A
| Article | Year |
|---|---|
Treating acquired haemophilia: an ethical conundrum.
Topics: Aged; Antipsychotic Agents; Ethics, Medical; Female; Hemophilia A; Humans; Paranoid Disorders; Rispe | 2000 |
Treating acquired haemophilia: an ethical conundrum.
Topics: Administration, Oral; Aged; Antipsychotic Agents; Clopenthixol; England; Ethics, Medical; Female; He | 2001 |